يحاول ذهب - حر
'A national tumor registry is the need of the hour'
July 2023
|Healthcare Radius
With disease burden on the rise, cancer has become a major healthcare challenge in India. Dr BS Ajaikumar, Founder and Executive Chairman, HealthCare Global Enterprises (HCG), offers experiential insights on tackling the challenge
-

How serious a problem is cancer in India?
As per the National Cancer Registry Program (NCRP), the cancer burden in India for 2021 was 2.67 crore and was expected to rise to 2.98 crore by 2025. Rapid urbanization has led to unhealthy eating habits, sedentary lifestyle, stress, pollution to name a few.
What challenges does India face when it comes to fighting the war on cancer?
The access to cancer screening and early detection facilities such as mammography, Pap smear, oral cancer detection are lacking, especially in the rural areas. Most of the top cancer centers are located in cities. Villagers find it difficult to get access to timely care. The treatment cost is enormous as it requires a multidisciplinary approach where multiple modalities of investigations and treatments such as surgery, chemotherapy, radiation, immunotherapy, etc.
There are very few government centers where investigations and treatments are available at subsidized rates. The resources at these centers are inadequate given India's huge population. It's difficult to access new drugs due regulatory requirements. Although new drugs get approved by some global agencies, it takes long to get them approved in India and the imported drugs are exorbitantly priced.
What are the breakthroughs in cancer care?
Many new cancer drugs, diagnostic methodologies, and technology advancements in terms of sophisticated machines with robotics for cancer surgeries and delivery of radiation are being developed today. The new drugs for immunotherapy evoke body's immune cells to detect and fight cancer. The drugs for targeted therapies target specific genes and proteins which help cancer cells survive and grow. These treatments have shown good results and are also less toxic.
What are the treatment options today?
هذه القصة من طبعة July 2023 من Healthcare Radius.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Healthcare Radius

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Translate
Change font size